Renal Cell Carcinoma Fuhrman Grade and Histological Subtype Correlate With Complete Polymorphic Deletion of Glutathione S-Transferase M1 Gene
Authors:
- 31 March 2010
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 183 (3) , 878-883
Abstract
Purpose: We outlined the putative significance of GST in renal cell carcinoma biology by investigating the influence of its deletion polymorphisms on renal cell carcinoma progression. Materials and Methods: Genomic DNA was purified from peripheral blood leukocytes. GSTM1 and GSTT1 genes were polymerase chain reaction amplified and gene fragments were separated by agarose gel electrophoresis. Intact GSTM1 and GSTT1 alleles were identified by the presence of 230 and 480 bp fragments, respectively. Genotypes were associated with clinicopathological variables and survival. Results: Of 147 patients with renal cell carcinoma 80 (54%) had the GSTM1 null and 27 (18%) had the GSTT1 null genotype. The GST genotype distribution did not differ significantly from that in 112 controls without renal cell carcinoma. However, the GSTM1 null genotype was associated with 60% lower odds of the papillary subtype (OR 0.40, 95% CI 0.18 to 0.92, p = 0.032), lower Fuhrman grade (chi-square 9.77, p = 0.008) and a lower risk of metastatic disease in patients with the clear cell subtype (chi-square 4.48, p = 0.034). Of patients with the clear cell subtype those with the GSTM1 null genotype had improved cancer specific survival (p = 0.0412). GSTT1 did not correlate with any pathological variable except age at renal cell carcinoma onset since patients with renal cell carcinoma and the GSTT1 null genotype were significantly younger than their counterparts (mean ± SD age 58.5 ± 14.2 vs 65.4 ± 12.8 years, p = 0.016). Conclusions: GSTM1 deletion polymorphism impacts renal cell carcinoma histological subtype, Fuhrman grade and metastatic behavior while GSTT1 deletion leads to renal cell carcinoma onset at a younger age. In patients with clear cell renal cell carcinoma the GSTM1 null genotype may be associated with better prognosis.Keywords
This publication has 21 references indexed in Scilit:
- Molecular Biology of Renal Cortical TumorsUrologic Clinics of North America, 2008
- Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphismsCarcinogenesis, 2008
- Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancerWorld Journal of Urology, 2007
- Glutathione S-transferase polymorphisms: cancer incidence and therapyOncogene, 2006
- Gender, smoking, glutathione--transferase variants and bladder cancer incidence: a population-based studyCancer Letters, 2005
- Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicalsOccupational and Environmental Medicine, 2003
- Glutathione S-Transferase Mu Modulates the Stress-activated Signals by Suppressing Apoptosis Signal-regulating Kinase 1Journal of Biological Chemistry, 2001
- Glutathione S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survivalInternational Journal of Gynecological Cancer, 2001
- Population Attributable Risk of Renal Cell Cancer in MinnesotaAmerican Journal of Epidemiology, 1998
- Glutathione S-transferase polymorphisms: influence on susceptibility to cancerChemico-Biological Interactions, 1998